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Adequate cellular in-growth into biomaterials is one of the fundamental requirements of scaffolds used in
regenerative medicine. Type I collagen is the most commonly used material for soft tissue engineering, because it
is nonimmunogenic and a highly porous network for cellular support can be produced. However, in general,
adequate cell in-growth and cell seeding has been suboptimal. In this study we prepared collagen scaffolds of
different collagen densities and investigated the cellular distribution. We also prepared a hybrid polymer–
collagen scaffold to achieve an optimal cellular distribution as well as sufficient mechanical strength. Collagen
scaffolds [ranging from 0.3% to 0.8% (w/v)] with and without a mechanically stable polymer knitting [poly-
caprolactone (PCL)] were prepared. The porous structure of collagen scaffolds was characterized using scanning
electron microscopy and hematoxylin-eosin staining. The mechanical strength of hybrid scaffolds (collagen with
or without PCL) was determined using tensile strength analysis. Cellular in-growth and interconnectivity were
evaluated using fluorescent bead distribution and human bladder smooth muscle cells and human urothelium
seeding. The lower density collagen scaffolds showed remarkably deeper cellular penetration and by combining
it with PCL knitting the tensile strength was enhanced. This study indicated that a hybrid scaffold prepared from
0.4% collagen strengthened with knitting achieved the best cellular distribution.
Introduction
Adequate cellular in-growth and acceptance andreplacement of biomaterials are prerequisites for the
successful engineering of soft tissues. It is one of the four
fundamental needs of scaffolds as defined by Hollister.1
After filling the defect (form), it should temporarily support
everyday functional demands (function), it should enhance
tissue regeneration (formation), and this should be in such a
format that the end user, the surgeon, can readily implant
and attach to tissues surrounding the defect (fixation). Fail-
ure of cell in-growth into the implanted material is suggested
to contribute to unwanted formation of scar tissue, resulting
in little flexibility and pliability.2 This is true for situations
where unmodified biomaterials are applied as well as for
situations in which autologous cells are seeded onto the
scaffold before implantation.
Type I collagen is the most commonly used biomaterial for
soft tissue. It is highly abundant in the human body, and it is
biocompatible,3 low immunogenic, structurally supports cell
growth,4 and provides a natural environment for cell
growth, differentiation, and wound repair. These excellent
qualities have made collagen a preferred material for re-
generative medicine purposes for more than a decade.5 In
general, collagen scaffolds are produced by lyophilization of
collagen solutions followed by cross-linking to achieve better
mechanical characteristics and to lower antigenicity.6 In
earlier studies using collagen scaffolds prepared from 0.8%
(w/v) type I collagen, we noticed poor cellular in-growth
into the scaffolds.7 Thus, despite the highly porous character
of collagen scaffolds, cell in-growth must be improved to
achieve a better outcome.
Many studies have been performed to enhance the cell
distribution inside scaffolds: static seeding and dynamic
seeding. Static seeding, which is the most common tech-
nique, includes surface seeding8 and injection seeding into
the scaffold.9 Dynamic seeding includes spinner flask seed-
ing,10 agitation in a bioreactor,11,12 and perfusion.13 Dynamic
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seeding is effective and the cell proliferation might be im-
proved by physical agitation.14 Another approach is to im-
prove the characteristics of the construct. We hypothesized
that scaffold interconnectivity, leading to improved cell
penetration, can be enhanced by decreasing the collagen
content. Nevertheless, by lowering the collagen content, the
mechanical properties of the collagen diminish and handling
becomes impossible (decreased fixation). Combining the
scaffold with other materials like polymers may alleviate this
problem. Many clinically applicable materials are available
for this purpose, for example, poly-glycolic acid, poly-lactic
acid, and poly-caprolactone (PCL). In this study we intro-
duced a new hybrid collagen–polymer scaffold with optimal
cellular distribution and mechanical strength. As an example
for a multilayered organ, we used the bladder, and investi-
gated the cell distribution in the novel construct and enhance
the engineering of this organ.
Materials and Methods
Collagen suspension
Collagen scaffolds were prepared from purified type I
collagen as described by Pieper et al.15 Insoluble type I
collagen fibrils were purified from pulverized bovine
Achilles tendon. The purification consisted of washings
with diluted acetic acid, aqueous NaCl solutions, urea, ac-
etone, and demineralized water. Collagen [0.3%, 0.4%,
0.5%, 0.6%, 0.7%, and 0.8% (w/v)] was suspended in 0.25 M
acetic acid and swollen overnight at 4C. Then, the collagen
was homogenized on ice using a Potter-Elvehjem homoge-
nizer. Air bubbles were removed by centrifugation (10 min,
250 g at 4C) and suspensions were poured into six-well
plates.
Poly-caprolactone
PCL was purchased from Sigma-Aldrich. The molecular
weight is 80,000 g/mol. Knittings were prepared from PCL
threads,16 which were knitted into sheets according to
the stockinet structure using knitting machinery (Lawson
Hemphil).
Hybrid scaffolds
For the hybrid scaffolds the bovine collagen solution was
poured on top of the man-made PCL knittings. Air bubbles
were removed using an additional centrifugation step
(10 min, 250 g at 4C). The scaffolds were subsequently
frozen and lyophilized in a Zirbus Sublimator 500II. Carbo-
diimide cross-linking was performed to cross-link the scaf-
folds.17 In brief, lyophilized scaffolds were preincubated in
2-morpholinoethane sulfonic acid buffer in 40% ethanol (pH 5)
overnight at 4C. Cross-linking was performed with 33 mM
EDC [N-ethyl-3-(3-demethylaminopropyl)carbodiimide] and
6 mM NHS (N-hydroxysuccimide) in 50 mM 2-morpholi-
noethane sulfonic acid (pH 5.0) containing 40% ethanol for
4 h at 20C. The scaffolds were then washed in 0.1 M
Na2HPO4, 1 M NaCl, 2 M NaCl, and water followed by 70%
ethanol and stored at - 20C. Before use, the scaffolds were
washed in 70% ethanol (4 · 1 h and 1· overnight), followed
by washings in sterile phosphate-buffered saline (PBS; pH
7.4, 4· 1 h, 1· overnight), and followed by an overnight
incubation in the culture medium.
Scanning electron microscopy
The structure of hybrid collagen–PCL scaffolds was ex-
amined by a scanning electron microscope (SEM) ( JSM-6310;
JEOL). Scaffolds were fixed with 2% (v/v) gluteraldehyde,
and then dehydrated by graded series ethanol (30%–100%)
and finally dried using the critical point dryer (Polaron;
Quorum Technologies). Samples were sputtered with gold
for 60 s by Scancoat Six SEM Sputter Coater (Temescal) be-
fore being studied.
Determination of cross-linking
Samples were incubated with 4% (w/v) NaHCO3 in water
for 30 min at 21C, and 0.5% (w/v) 2,4,6-trinitrobenzene
sulfonic acid solution was added and the samples were in-
cubated for 2 h at 40C. The degree of cross-linking was
determined by the change of free amine groups by measur-
ing the absorbance of resultant trinitrophenylated amine
complex at 420 nm (Biorad).
Determination of water retention
Samples were incubated with water for 24 h at 21C on the
shaker. The weight of wet scaffolds was weighed after re-
moving the excess water with blotting paper. The weight of
dry scaffolds was determined after freezing and lyophiliza-
tion (VirTis Sentry) overnight. At each percentage of collagen
scaffolds, six samples were tested. The water retention was
calculated according to the formula:
Water uptake (wt%)¼ (WwetWdry)
Wdry
· 100, (1)
Where Wwet is the wet weight after blotting and Wdry is the
weight after drying.
Ultimate tensile strength
Samples were preincubated in 0.9% NaCl, cut into strips,
and placed between clamps in a bioreactor (Bose Electroforce
Biodynamic Bioreactor). The measurements were recorded and
controlled by the WinTest v4.1. The elongation speed was set at
20 mm/min and forces were recorded with a 22 N load cell.
The distance between clamps was 10 mm for collagen samples
and 5 mm for PCL plus collagen samples. The valley and peak
distance was 12 mm. The measurements were repeated at least
4 times for each scaffold of a particular collagen density.
Measurement was valid when a sample broke in the middle.
Distribution of fluorescent beads
The scaffolds were washed five times in PBS before bead
seeding. The fluorescent beads (10-mm diameter, 488 nm,
Flow Check; Beckman Coulter) were washed using 5% (w/v)
bovine serum albumin (BSA; Sigma Aldrich) in PBS. The
fluorescent beads were seeded at a density of 2 · 106 beads/
cm2 scaffold and incubated overnight under continuous
shaking at 21C. The bead-seeded scaffolds were collected
and incubated for 20 min in Tissue-Tek (Sakura Finetek
Europe B.V.) and snap-frozen. Cryostat sections (5 mm) were
collected on gelatin-coated slides [0.5% gelatin (w/v), 0.05%
potassium chrome (III) sulfate (w/v), and demi-water], fixed
with 100% methanol, and air dried for 1 h at 21C.
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Cell culture
Human bladder smooth muscle cells (HBSMCs) were
purchased from Sciencell (Carlsbad). HBSMCs were cultured
in smooth muscle cell medium (SMCM, Cat. 1101; Sciencell)
with 2% (v/v) fetal bovine serum, 1% (v/v) smooth
muscle cell growth supplement, and penicillin (100 iU/mL)–
streptomycin (100mg/mL). Human urothelial cells (ScaBER,
derived from squamous cell carcinoma of human bladder)
were cultured in RPMI-1640 medium (Cat. 21870; Invitrogen)
with 10% (v/v) fetal calf serum, without glutamin, and
penicillin (100 iU/mL)–streptomycin (100mg/mL). Cells
were cultured and expanded at 37C and 5% CO2 in humid
atmosphere air.
Cell seeding
Static seeding of HBSMCs on the scaffold was performed
using 2.6 · 106 cells/cm2. Cells were cultured for 14 days
and medium was replaced every 2–3 days. Thereafter, the
scaffolds were incubated in RPMI-1640 medium overnight
followed by an urothelial cell seeding step. ScaBER cells
(6.6 · 106 cells/cm2) were seeded, and scaffolds were incu-
bated for an additional 7 days.
Immunohistochemistry
Cell-seeded scaffolds were fixed in 4% (v/v) formalin in
PBS overnight and embedded in paraffin. Four-micrometer
sections were cut (Microm), deparaffinized in xylene, and
rehydrated using a graded series of ethanol, and stained with
hematoxylin-eosin (H&E).
For immunohistochemistry analysis, 5-mm cryostat sec-
tions of slides were fixed in methanol for 10 min at - 20C
and air dried for 1 h at 21C. Sections were blocked with 10%
(v/v) normal goat serum in PBS for 1 h. Then, sections were
incubated with various primary antibodies, such as rabbit
anti-bovine type I collagen (Millipore; 10 mg/mL), mouse
anti-human RGE53 (MUbio BV; 10mg/mL), rabbit anti-
human vimentin (Pathology, UMC St. Radboud Nijmegen;
1:200), and mouse anti-human CD90 (Dianova GmbH;
40mg/mL), in blocking buffer for 1 h at 21C in a wet
chamber. The primary antibodies were developed with goat
anti-rabbit Alexa-488 (Invitrogen; 10mg/mL) or goat anti-
mouse Alexa 594 (Invitrogen; 10mg/mL). Nuclei were
counterstained with 4¢,6-diamidino-2-phenylindole in Pro-
long gold mount medium (Invitrogen). The samples were
evaluated by fluorescence microscopy (LEICA DC 300F).
Results
Characterization of the collagen scaffolds
SEM and H&E and images of the different collagen scaf-
folds are shown in Figures 1 and 2. The scaffolds had the
typical honeycomb morphology.18 The pore size of all col-
lagen scaffolds ranged between 75mm and 150mm, and the
degree of cross-linking was *43%,18 regardless of collagen
density. The water retention capacity of the scaffolds was
highly similar after 24 h of incubation. In general, different
density scaffolds revealed more connections between pores
in the lower density scaffolds as compared with the higher
density scaffolds (Fig. 1).
The hybrid scaffolds were prepared by pouring the col-
lagen solutions on top of the PCL knitting. Despite the fact
that no additional measures were taken, the collagen and
PCL appeared to be adequately connected (see Fig. 2). The
woven structure of the PCL knitting may have aided in an
adequate collagen distribution.
Tensile strength experiments were performed to deter-
mine the mechanical properties of the scaffolds with and
without PLC knitting (Fig. 3a). The strength of scaffolds in-
creased slightly as the density of the collagen increased
(R2 = 0.97; p= 0.0008). Further, hybrid scaffolds were much
stronger compared with scaffolds composed of collagen
alone (Fig. 3b, c). Even at the highest tensile force applied,
the PCL–collagen scaffold did not break but deformed; the
FIG. 1. Microscopic characterization of the cross-sectioned collagen scaffolds. Scanning electron microscopy (A–F) and
hematoxylin-eosin of different collagen scaffolds (E–K) indicate that the interconnection is related to the collagen content.
Scaffolds with lower collagen content show more interconnectivity between the pores (more open lamellae).
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collagen layers broke and slid from the PCL and the mor-
phology of the PCL knitting was irreversibly changed.
To further investigate the influence of the collagen con-
centration on the interconnectivity of the resultant different
scaffolds, the distribution of fluorescent beads was investi-
gated. To mimic cell penetration, 10-mm-diameter beads were
used, comparable with the size of animal eukaryotic cells.
The distribution of the beads was highly dependent on
the collagen density; at lower collagen densities the beads
were more evenly distributed and penetrated deeper into the
scaffold (see Fig. 4). Beads presented throughout the 0.3%
and 0.4% scaffold and a less homogeneous distribution was
noted for the 0.5% and 0.6% scaffold, whereas the fluorescent
beads were mainly on the surface of the 0.7% and 0.8%
collagen scaffolds.
Cell distribution
To mimic multilayered cell growth, human bladder
smooth muscle cells (HBSMCs) were seeded onto the scaf-
folds followed by urothelial (ScaBER) cells. HBSMCs were
allowed to grow for 14 days, in an effort to generate scaffolds
mimicking the urinary bladder wall, the natural stratum for
urothelial cells. HBSMCs were visualized with an anti-
human smooth muscle cell marker (CD-90 and vimentin).
The distribution of HBSMCs inside the scaffolds was more
homogeneous in the lower collagen density scaffolds (0.3%
and 0.4% scaffolds) where they almost completely covered
the depth of the scaffolds (see Figs. 5 and 6). HBSMCs
in-growth of scaffolds of higher collagen content was less
extensive, and less dispersed. Inclusion of PCL did not in-
fluence the cell distribution.
Seeding of bladder cells resulted in urothelial cell growth
restricted to the scaffold surface, mimicking the build-up of
normal bladder tissue. Even after 3 weeks of culture, the
scaffolds supported the cells and did not lose integrity, re-
gardless of collagen content. The distribution of the bladder
cells was visualized with an anti-human cytokeratin marker
(RGE-53) (see Fig. 6). Comparison of cell markers of cells
grown under standard cell culture conditions did not reveal
any difference with cells grown on scaffolds.
Discussion
For soft tissue engineering, adequate cell colonization is
crucial. Failure of cellular in-growth can lead to scar forma-
tion, and foreign body reactions leading to an undesired end
result. Collagen has been applied as biomaterial for soft tis-
sue engineering for many years, but the issue of adequate cell
in-growth is still unresolved.7 Addition of migrational and
FIG. 2. Schematic overview
of preparation hybrid scaffold.
Type I collagen (A) plus
poly-caprolactone (PCL)
knitting (B) is a hybrid scaffold
(C). Collagen scaffold and PCL
knitting were imaged by light
microscopy (4 · and 10 · ).
Collagen is integrated into
PCL knitting. Arrows indicate
the collagen (D). Type I
collagen and PCL were imaged
by scanning electron
microscope (E). Collagen is
adequately connected to PCL.
Taking a close look of PCL,
collagen is well distributed
through it (50 · and 250 · ).
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differentiating cues may alleviate this problem, but thus far
success has been limited.19 One of the parameters that
influence cell distribution is scaffold porosity and inter-
connectivity. To improve the cell distribution in honeycomb
collagen scaffolds and to optimize their use for soft tissue
engineering, we prepared 0.3% to 0.8% (w/v) collagen
scaffolds and included a rigid knitting to improve the me-
chanical and handling characteristics. The porosity of all
scaffolds was similar, but lowering the collagen content re-
sulted in higher interconnectivity and improved cellular in-
growth. Cells remained on the surface of the higher density
collagen scaffolds, but almost completely invaded the
scaffolds of the lowest density, leading to a scaffold almost
homogeneously occupied with HBSMCs. Thus, the func-
tionality of the collagen scaffolds with regard to the cellular
distribution was improved by lowering the collagen density.
The low-density collagen scaffolds were very fragile,
which made them unsuitable for in vivo use. To improve the
mechanical strength polymer knitting was incorporated. This
resulted in a hybrid scaffold with significantly increased
FIG. 3. Tensile test of collagen scaffold with and without PCL (a). The mechanical strength increased slightly with the
increase of collagen density. The strength of scaffolds with PCL is higher than that of collagen-alone scaffolds. (b, c)
Individual tensile strength measurements of 0.8% collagen scaffold without (b) and with PCL (c). Please note plateau value at
7.8 N in (c), suggesting that beyond 7.8 N PCL distortion occurs.
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FIG. 4. Bead distribution in collagen scaffolds
(0.8%–0.3%, A–F). Type I collagen was devel-
oped by Alexa 594 and the fluorescent beads
were tagged with Alexa 488. Beads and collagen
scaffolds were imaged by fluorescent micros-
copy (4· ). Beads penetrate deeply into 0.3% and
0.4% collagen scaffolds. In 0.7% and 0.8% colla-
gen scaffolds, beads mainly stay on the surface
of scaffolds.
FIG. 5. Immunofluorescence (IF) analysis of
cell distribution in different densities (from 0.8%
to 0.3%, A–F) of collagen scaffold. Type I colla-
gen was developed by Alexa 594 (red), human
bladder smooth muscle cells (HBSMCs) was
developed by Alexa 488 (green), and all nuclei
were counterstained by 4¢,6-diamidino-2-phe-
nylindole (DAPI) (blue). HBSMCs and collagen
scaffolds were imaged by fluorescence micros-
copy (10· ). Smooth muscle cells (HBSMCs) are
located in the scaffold. More HBSMCs are dis-
tributed through the 0.3% and 0.4% scaffolds
and less cells penetrate 0.7% and 0.8% scaffolds.
Cells on top of the surface that are not smooth
muscle cell positive are urothelial cells.
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mechanical and functional characteristics; cell in-growth
was greatly enhanced due to the lower collagen content
whereas the hybrid scaffold could be handled easily due to
the incorporation of the polymer. The polymer used, PCL, is
frequently used as biomaterial. The degradation time of PCL
is *6 to 9 months in vivo, very suitable for implantable
systems where scaffolds must provide temporary mechanical
support for a longer period until the regenerated tissue can
support mechanical loads.20 Incorporation of supportive
materials other than PCL—for instance, copolymers of lactic
acid, glycolic acid, or trimethylene carbonate by which the
degradation time can be tailored19,21–23—should greatly en-
hance the implementation possibilities for soft tissues.
Similar to our scaffolds, PLGA- and PLLA-enforced hybrid
scaffolds have been prepared for cartilage regeneration.24,25
In these hybrids a favorable cell distribution was observed,
most likely related to the unidirectional orientation of the
pores. In our honeycomb-structured scaffolds that are nee-
ded to regenerate complex, multilayered tissues composed of
multiple cell types, we needed to decrease the collagen
content of the hybrid scaffolds to achieve a favorable cell
distribution for soft tissue regeneration. Through small
changes in collagen content we could control the cellular
distribution.
To further quantify the effect of lowering the collagen
content, we studied the distribution of 10-mm-diameter
fluorescent beads. The distribution of the beads was identical
to the distribution of cells, with better bead penetration at the
lower collagen densities. This again demonstrates that the
interconnectivity increased by lowering the collagen content.
Obviously, the bead distribution does not truly reflect the
cell distribution after cell seeding, as other factors such as cell
surface influence this distribution. The obvious advantages
of the beads are the rapidity with which the results are ob-
tained; the consistency, because variability due to the use of
different cells is lacking; and the objectivity, with the possi-
bility to vary bead size to judge interconnectivity and mea-
sure bead penetration.26 Many studies have applied different
seeding methods to improve the cellular distribution in
honeycomb-like scaffolds. Different procedures of dynamic
cell seeding have been attempted, including centrifugation,27
rotation,28 magnetic field,29 and vacuum,30 in a bioreactor.
FIG. 6. IF double staining
of HBSMCs and ScaBER in
different densities (0.8%,
0.6%, and 0.4%) of collagen
scaffold. HBSMCs were
developed by Alexa 488
(green), ScaBER was
developed by Alexa 594
(red), and all nuclei were
counterstained by DAPI
(blue). HBSMCs and
ScaBER in scaffolds were
imaged by fluorescence
microscopy (10 · and 40· ).
HBSMCs are located under
the ScaBER cells as natural
stratum for urothelial cells.
ScaBER cells are always
on top of the scaffolds
regardless of the collagen
density. More HBSMCs are
distributed in the low-
density scaffolds.
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Nevertheless, almost invariably, the cell distribution was
limited to the scaffold surface with little spreading
throughout the scaffold. Coating of PET fabrics with 0.3%
collagen (without cross-linking) demonstrated an even cel-
lular distribution throughout 1.5-mm scaffolds28 similar to
our observations with 5-mm-thick scaffolds prepared from
0.3% collagen. Our results suggest that the efficiency of cell
colonization largely depends on the collagen density of the
scaffold. Most likely, the higher interconnectivity in the
scaffold facilitates cellular migration since collagen degra-
dation is not necessary to colonize adjacent pores of the
scaffold. Since cellular in-growth appears to be greatly de-
pendent on the pore interconnectivity, it is not unexpected
that static seeding at higher cell density did not lead to better
and more homogeneous cell growth.
Lowering the collagen content may be more beneficial in
achieving a homogeneous cell distribution than active cel-
lular seeding. However, improved cell in-growth in vivo in
lower collagen content scaffolds remains to be studied. In
addition, active cell seeding in this low collagen content,
polymer-supported scaffolds may lead to a more homoge-
neous cell distribution.
Conclusion
In summary, the functionality of collagen scaffolds can be
greatly improved by lowering the collagen content and in-
cluding polymer knitting, leading to a versatile scaffold with
new opportunities for soft tissue engineering.
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